Distal small bowel bypass for weight regain after gastric bypass: safety and efficacy threshold occurs at <70% bypass.
BACKGROUND
For patients with poor weight loss (WL) after Roux-en-Y gastric bypass (RYGB) there are few well-tolerated and effective surgical options. Revision to distal bypass by shortening of the common channel (CC) induces significant WL but often produces protein calorie malnutrition (PCM) and severe diarrhea.


OBJECTIVE
The aim of this study was to identify a safe and effective threshold for distal small bowel bypass when done for revision of gastric bypass.


METHODS
Academic Institution, United States.


METHODS
We performed revision of RYGB for WL in 20 patients by shortening the CC to a new length of 120-300 cm. The Roux limb length was unchanged. WL and PCM were monitored. A threshold for percent of small bowel bypassed at which PCM was avoided was retrospectively determined. WL was then compared in patients above and below this threshold. Five patients completed a 250-kcal mixed meal challenge before and 3 months after revision to determine selected gut hormone responses.


RESULTS
Bypassing ≥70% small bowel resulted in PCM in 4 of 10 patients but in none of 10 patients below that threshold. PCM was observed as late as 2 years after revision and necessitated rerevision by lengthening of the CC in 3 patients. Additionally, nocturnal diarrhea was more common and more intractable when ≥70% bypass was done. Both groups had significant excess body WL over 2 years, but it was greater in patients with ≥70% bypass (47±19 versus 26±17; P<.05). A favorable gut hormone response was observed with 3-hour decrease in glucose-dependent insulinotropic peptide (GIP) by 25% and increase in glucagon-like peptide-1 (GLP-1) by 25%, whereas fasting peptide-YY (PYY) increased by 71% (P<.05 for all).


CONCLUSIONS
Revision of RYGB to distal bypass when it is <70% of a patient's small bowel length results in an acceptable balance of WL and a positive safety profile. WL may be mediated through an enhanced gut hormone effect, an aversion to ingested fat, and possibly other mechanisms.
State University of New York at Buffalo School of Medicine, Buffalo, New York, USA. Electronic address: jcaruana@ecmc.edu.
Joseph A
JA
Caruana
State University of New York at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, New York, USA.
Scott V
SV
Monte
State University of New York at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, New York, USA.
David M
DM
Jacobs
State University of New York at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, New York, USA.
Catherine
C
Voytovich
State University of New York at Buffalo School of Medicine, Buffalo, New York, USA.
Husam
H
Ghanim
State University of New York at Buffalo School of Medicine, Buffalo, New York, USA.
Paresh
P
Dandona
D000328:Adult; D000714:Anastomosis, Surgical / Q000379:methods; D005260:Female; D005500:Follow-Up Studies; D015390:Gastric Bypass / Q000009:adverse effects*; D006801:Humans; D007421:Intestine, Small / Q000601:surgery*; D008297:Male; D009767:Obesity, Morbid / Q000503:physiopathology / Q000601:surgery*; D012086:Reoperation; D012189:Retrospective Studies; D013997:Time Factors; D015430:Weight Gain / Q000502:physiology*
Gastric bypass; Gut hormones; Poor weight loss; Revision surgery